Pharmaceutical Cartridges Research Report 2024: Global Market to Reach $2.8 Billion by 2030 - Growing Adoption of Dual-Chamber Cartridges for Lyophilized Drugs and Reconstitution Expands Opportunities
January 09, 2025 04:06 ET
|
Research and Markets
Dublin, Jan. 09, 2025 (GLOBE NEWSWIRE) -- The "Pharmaceutical Cartridges - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
Final Study Completed for Cingulate’s Lead Asset CTx-1301
January 07, 2025 07:30 ET
|
Cingulate Inc.
No Serious Adverse Events ReportedSubmission of New Drug Application Targeted for Mid 2025 KANSAS CITY, Kan., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical...
Oral Proteins and Peptides Market Report 2025: Key Trends Shaping the Market Over the Next Ten Years and Beyond
January 02, 2025 04:22 ET
|
Research and Markets
Dublin, Jan. 02, 2025 (GLOBE NEWSWIRE) -- The "Oral Proteins and Peptides Market Report" has been added to ResearchAndMarkets.com's offering.The oral proteins and peptides market size has grown...
1,202 Drug Delivery Collaboration and Licensing Deals Trends Report and Directory 2024 by Company A-Z, Deal Type and Therapeutic Target
December 31, 2024 05:31 ET
|
Research and Markets
Dublin, Dec. 31, 2024 (GLOBE NEWSWIRE) -- The "Drug Delivery Collaboration and Licensing Deals 2019-2024" report has been added to ResearchAndMarkets.com's offering.Drug Delivery Collaboration and...
India Drug Delivery Devices Market 2024, with Profiles of Pfizer, Novartis, GlaxoSmithKline, India Medtronic, Cardinal Health, B. Braun Medical, Sun Pharmaceutical, 3M, Cipla & Bayer Zydus Pharma
December 10, 2024 07:25 ET
|
Research and Markets
Dublin, Dec. 10, 2024 (GLOBE NEWSWIRE) -- The "India Drug Delivery Devices Market, By Region, Competition, Forecast and Opportunities, 2020-2030F" report has been added to ResearchAndMarkets.com's...
Oral Proteins & Peptides Market Research: Semaglutide, Linaclotide, Calcitonin,GLP-1 Receptor Agonist, GEP, CGRP, Diabetes, Gastroenterology, Genetic Disorder - Global Forecast to 2029
November 08, 2024 11:32 ET
|
Research and Markets
Dublin, Nov. 08, 2024 (GLOBE NEWSWIRE) -- The "Oral Proteins & Peptides Market by Molecule (Semaglutide, Linaclotide, Calcitonin), Drug Class (GLP-1 Receptor Agonist, GEP, CGRP), Therapeutic...
Cingulate Reports Third Quarter 2024 Financial Results Reflecting $19.5 Million Increase in Working Capital to Advance ADHD Drug to Market
November 07, 2024 07:30 ET
|
Cingulate Inc.
KANSAS CITY, Kan., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...
Cingulate’s Shane Schaffer Joins Cast of Nationally Syndicated Big Biz Show
October 08, 2024 15:15 ET
|
Cingulate Inc.
KANSAS CITY, Kan., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Shane J. Schaffer, Chairman and CEO of Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed...
Cingulate Issued European Patent for Lead Asset CTx-1301 for the Treatment of ADHD
August 15, 2024 07:45 ET
|
Cingulate Inc.
KANSAS CITY, Kan., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...
Serina Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Highlights
August 09, 2024 16:15 ET
|
Serina Therapeutics, Inc.
HUNTSVILLE, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Serina Therapeutics (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug delivery...